ReviewIndian dermatology online journal2014
Cutaneous lupus erythematosus: An update.
Review in Indian dermatology online journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026Trial
- Development of Anti-Inflammatory Agents Utilizing DC-SIGN Mediated IL-10 Secretion in Autoimmune and Immune-Mediated Disorders: Bridging Veterinary and Human Health.International journal of molecular sciences · 2025Review
- Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: a case report and review of the literature.Frontiers in oncology · 2025Article
- Dermatological Manifestation of SLE Patients, Living in Aseer Region.Journal of family medicine and primary care · 2024Article
- Polyautoimmunity in patients with cutaneous lupus erythematosus: A nationwide sex- and age-matched cohort study from Denmark.JAAD international · 2023Article
- Granzyme B in Autoimmune Skin Disease.Biomolecules · 2023Review
- Novel role of long non-coding RNAs in autoimmune cutaneous disease.Journal of cell communication and signaling · 2022Review
- Epidemiology of Cutaneous Lupus Erythematosus Among Adults Over Four Decades (1976-2018): A Lupus Midwest Network (LUMEN) Study.Mayo Clinic proceedings · 2022Article
- Recent advances in cutaneous lupus.Journal of autoimmunity · 2022Review
- Cutaneous manifestations of acute kidney injury.Clinical kidney journal · 2022Review
- The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: a narrative review.Annals of translational medicine · 2021Review
- Variability of the rs333 in Polish patients with lupus erythematosus.Postepy dermatologii i alergologii · 2021Article
- Severe Granulomatous Rosacea with Cutaneous Lupus Erythematosus.The Journal of clinical and aesthetic dermatology · 2021Article
- Lupus Erythematosus Quality of Life Questionnaire (LEQoL): Development and Psychometric Properties.International journal of environmental research and public health · 2020Article
- Cutaneous and systemic connections in lupus.Current opinion in rheumatology · 2020Review
- Progression of Discoid Lupus to Lupus Panniculitis: An Unexplained and Likely Underreported Phenomenon.Cureus · 2020Article
- Temporomandibular Disorders and Oral Features in Systemic Lupus Erythematosus Patients: An Observational Study of Symptoms and Signs.International journal of medical sciences · 2020Observational
- Clinic experience in discoid lupus erythematosus: a retrospective study of 132 cases.Postepy dermatologii i alergologii · 2019Article
- Ustekinumab-induced subacute cutaneous lupus.JAAD case reports · 2019Article
- Subacute cutaneous lupus erythematosus inducing unilateral sensorimotor neuropathy.Rheumatology international · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lupus erythematosus (LE) is a chronic, autoimmune, multisystem disease that displays many diverse symptoms in which localized cutaneous LE (CLE) is on one end of the spectrum and severe systemic LE (SLE) on the other end. The underlying cause of LE is unknown but the etiology is thought to be multifactorial and polygenic. CLE is a disfiguring, chronic skin disease, with a significant impact on the patients' everyday life. CLE are further divided into three main subsets: Acute CLE (ACLE), subacute CLE (SCLE) and chronic CLE (CCLE), where classic discoid LE (DLE) is the most common form. These subsets are defined by clinical symptoms, average duration of symptoms and histological and serological findings, although, the three subtypes can have overlapping clinical features. CLE patients display well-defined skin lesions, often in sun-exposed areas. The disease often has a chronic and relapsing course that can be induced or aggravated by UV light. It is important to confirm a CLE diagnosis histopathologically by a biopsy and in that there are several differential diagnoses and because CLE is a chronic disease in which regular follow-up is important and systemic treatment is sometimes indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.